Table 1 |
|||||
|
Description of clinical surveillance sites and the characteristics of the catchment populations in relation to transmission intensity (PfPR2–10-Plasmodium falciparum parasite prevalence in children 2 to 10 years). |
|||||
|
Study Site [Map Reference] |
Dates (years) |
Malaria admissions |
BCS1 ≤ 2 recorded (Y/N) |
SMA2 recorded (Y/N) |
PfPR 2–10 (years recorded) [number examined] |
|
|
|||||
|
Kilifi North, Kenya [A] |
2004–07 (4) |
712 |
Y |
Y |
1.3 (2005–07) [828] |
|
Hodeidah, Yemen [B] |
2002–04 (1.75) |
283 |
Y |
Y |
1.7 (2005–06) [5886] |
|
Bakau, The Gambia [C] |
1992–94 (3) |
99 |
Y |
N |
2.1 (1988) [386]3 |
|
Taiz, Yemen [D] |
2002–04 (1.75) |
1049 |
Y |
Y |
5.7 (2005–06) [4908] |
|
Kilimanjaro, Tanzania [E] |
2002–03 (1) |
162 |
Y |
Y |
6.2 (2001–02) [382] |
|
Humera, Ethiopia [F] |
1994–95 (1) |
458 |
N |
Y |
12.6 (1995) [616] |
|
Kabale, Uganda [G] |
2002–03 (1.5) |
160 |
Y5 |
Y |
18.0 (2006) [64]4 |
|
Kilifi South Junju, Kenya [A] |
2005–07 (3) |
92 |
Y |
Y |
25.9 (2005–07) [1601] |
|
Mponda, Malawi [H] |
1994–95 (1) |
356 |
Y |
Y |
33.0 (1996) |
|
Foni Kansala, The Gambia [I] |
1994–95 (2) |
193 |
Y |
Y |
34.1 (1991–92) [117] |
|
Korogwe, Tanzania [J] |
2002–03 (1) |
3948 |
Y |
Y |
34.9 (2000–02) [927] |
|
Sukuta, The Gambia [C] |
1992–95 (4) |
605 |
Y |
N |
42.4 (1996) [125] |
|
Kilifi South Chonyi, Kenya [A] |
1999–01 (3) |
346 |
N |
Y |
43.0 (1999–01) [1918] |
|
Kilifi North, Kenya [A] |
1990–95 (5) |
1358 |
Y |
Y |
51.9 (1995) [540] |
|
Siaya, Kenya [K] |
1992–96 (3) |
715 |
Y |
Y |
75.1 (1995) [570] |
|
Kilifi South, Kenya [A] |
1992–96 (4) |
766 |
Y |
Y |
76.9 (1996) [212] |
|
Namawala/Michenga, Tanzania [L] |
1991–92 (1) |
144 |
Y |
Y |
87.5 (1989–91) [3947] |
|
|
|||||
|
1BCS – Blantyre Coma Score 2 SMA Severe Malaria Anaemia defined as Hb <5 gm/dl or PCV<15% 3 The estimate of PfPR was not temporally matched however it was regarded as a legitimate estimate for this peri-urban community four years later when the clinical surveillance data began. 4 Kabale is a high altitude area and while there were 3 years difference in the estimation of PfPR and the clinical surveillance period the estimate of infection prevalence is regarded as a good approximation. 5 The investigators used a BCS ≤ 2 to describe cerebral malaria in children aged less than 5 years old and a Glasgow Coma score [32] of ≤ 8 for children 5–9 years. |
|||||
|
Okiro et al. Malaria Journal 2009 8:4 doi:10.1186/1475-2875-8-4 |
|||||